ARTEMISMEDArtemis Medicare Services Limited
Other · · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹270.75
▲ 0.52%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)—
P/E118.23
P/B4.59
PEG3.84
ROE %11.63
ROCE %—
Debt / Equity0.28
EPS2.29
Revenue Growth %16.40
Profit Growth %30.80
Dividend Yield %0.17
Promoter Holding %80.97
FII Holding %1.50
DII Holding %—
Beta0.27
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 64% | ₹270.75 | ₹261.30 | ₹287.55 | 1.78 |
HOLDConviction 74%
The picture
- • Revenue growth: 16.4% YoY
- • Profit growth: 30.8% YoY
- • Debt/Equity: 0.28
- • RSI: 52
- • MACD: bullish
- • Price vs EMA21: above
- • Pullback to 21-EMA signal (setup quality 64%)
Bull case
- • Revenue growth: 16.4% YoY
- • Profit growth: 30.8% YoY
- • Debt/Equity: 0.28
- • RSI: 52
Bear case
- • Valuation vs sector: P/E 118.2 vs sector 19.2
- • PEG ratio: 3.84
- • Volume: 0.7x 20-day average
- • Volume trend: 0.9x baseline
Key risks
- • Valuation vs sector: P/E 118.2 vs sector 19.2
- • PEG ratio: 3.84
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹270.75
Stop Loss
₹254.99
risk 5.8%
Target 1 (1.5R)
₹294.39
+8.7%
Target 2 (3R)
₹318.03
+17.5%
Support (20d)
₹257.57
Resistance (52w)
₹297.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹15.76/share
ATR (volatility)
₹9.45
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹9.45). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
57
Technical
69
Momentum
70
Risk (safety)
64